{"pmid":32419777,"pmcid":"PMC7225718","title":"No Need of Transforming Gastroenterology Units to COVID Units at the Time of SARS-COV2 Infection - A Single-Center Analysis from Northern Italy.","text":["No Need of Transforming Gastroenterology Units to COVID Units at the Time of SARS-COV2 Infection - A Single-Center Analysis from Northern Italy.","Dig Liver Dis","Zingone, Fabiana","Casadei, Cesare","Farinati, Fabio","Savarino, Edoardo","32419777"],"journal":"Dig Liver Dis","authors":["Zingone, Fabiana","Casadei, Cesare","Farinati, Fabio","Savarino, Edoardo"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32419777","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.dld.2020.05.010","keywords":["covid-19","gastroenterology ward","infusion","liver disease","sars-cov-2"],"topics":["Prevention"],"weight":1,"_version_":1667159284539981824,"score":9.490897,"similar":[{"pmid":32425991,"pmcid":"PMC7233236","title":"The liver in times of COVID-19: What hepatologists should know.","text":["The liver in times of COVID-19: What hepatologists should know.","The ongoing pandemic of coronavirus disease 2019 (COVID-19) pandemic poses a serious threat to healthcare systems globally. Information regarding to the how the infection affects the liver and relevance of pre-existing liver disease as a risk factor for acquiring the infection or having a severe disease are still scarce. Also, considerations to be considered in liver transplant patients or those having hepatocellular carcinoma or are under immunosuppressive therapy are being matter of analysis as information is being generated. Different treatments for COVID-19 are currently under study some of which may be associated to hepatotoxicity. In the present review we discuss current data on the COVID-19 and liver aiming to provide hepatologists with updated information to face this pandemic.","Ann Hepatol","Ridruejo, Ezequiel","Soza, Alejandro","32425991"],"abstract":["The ongoing pandemic of coronavirus disease 2019 (COVID-19) pandemic poses a serious threat to healthcare systems globally. Information regarding to the how the infection affects the liver and relevance of pre-existing liver disease as a risk factor for acquiring the infection or having a severe disease are still scarce. Also, considerations to be considered in liver transplant patients or those having hepatocellular carcinoma or are under immunosuppressive therapy are being matter of analysis as information is being generated. Different treatments for COVID-19 are currently under study some of which may be associated to hepatotoxicity. In the present review we discuss current data on the COVID-19 and liver aiming to provide hepatologists with updated information to face this pandemic."],"journal":"Ann Hepatol","authors":["Ridruejo, Ezequiel","Soza, Alejandro"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32425991","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.aohep.2020.05.001","keywords":["ace2, angiotensin-converting enzyme 2","alt, alanine aminotransferase","ards, acute respiratory distress syndrome","ast, aspartate aminotransferase","cdc, centers for disease control and prevention","covid-19, coronavirus disease 2019","evd, ebola virus disease","hbv, hepatitis b virus","hcc, hepatocellular carcinoma","icu, intensive care unit","il, interleukin","ilca, international liver cancer association","mafld, metabolic associated fatty liver diseases","nafld, non-alcoholic fatty liver disease","niddk, national institute of diabetes and digestive and kidney diseases","rdrp, rna-dependent rna polymerase","sars-cov-2","sars-cov-2, severe acute respiratory syndrome coronavirus 2","tnf-alpha, tumor necrosis factor-alpha","who, world health organization","coronavirus","immunosuppression","liver disease","nsp, non-structural proteins","transplantation, cirrhosis"],"topics":["Treatment"],"weight":1,"_version_":1667352728923275264,"score":63.39265},{"pmid":32454042,"title":"SARS-CoV-2 related liver impairment - perception may not be the reality.","text":["SARS-CoV-2 related liver impairment - perception may not be the reality.","J Hepatol","Philips, Cyriac Abby","Ahamed, Rizwan","Augustine, Philip","32454042"],"journal":"J Hepatol","authors":["Philips, Cyriac Abby","Ahamed, Rizwan","Augustine, Philip"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32454042","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.jhep.2020.05.025","keywords":["covid-19","dili","coronavirus","critical illness","hepatitis","liver disease","pandemic"],"weight":0,"_version_":1667881798438223873,"score":59.40798},{"pmid":32251539,"title":"COVID-19 and liver disease.","text":["COVID-19 and liver disease.","Since December 2019, patients with unexplained pneumonia have been found in Wuhan, Hubei Province, China, which was caused by a novel coronavirus that had not been previously identified (1). Tentatively defined as 2019 novel coronavirus (2019-nCoV), the pathogen has now been named Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) (2), while the disease termed Coronavirus Disease 2019 (COVID-19).","Liver Int","Sun, Jian","Aghemo, Alessio","Forner, Alejandro","Valenti, Luca","32251539"],"abstract":["Since December 2019, patients with unexplained pneumonia have been found in Wuhan, Hubei Province, China, which was caused by a novel coronavirus that had not been previously identified (1). Tentatively defined as 2019 novel coronavirus (2019-nCoV), the pathogen has now been named Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) (2), while the disease termed Coronavirus Disease 2019 (COVID-19)."],"journal":"Liver Int","authors":["Sun, Jian","Aghemo, Alessio","Forner, Alejandro","Valenti, Luca"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32251539","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1111/liv.14470","keywords":["covid-19","sars-cov-2","coronavirus","infection","liver disease"],"locations":["Wuhan","Hubei","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Mechanism","Treatment","Prevention"],"weight":1,"_version_":1666138490931249152,"score":57.98704},{"pmid":32277423,"pmcid":"PMC7146073","title":"First considerations on the SARS-CoV-2 epidemic in the Dialysis Units of Piedmont and Aosta Valley, Northern Italy.","text":["First considerations on the SARS-CoV-2 epidemic in the Dialysis Units of Piedmont and Aosta Valley, Northern Italy.","J Nephrol","Manganaro, Marco","Baldovino, Simone","32277423"],"journal":"J Nephrol","authors":["Manganaro, Marco","Baldovino, Simone"],"date":"2020-04-12T11:00:00Z","year":2020,"_id":"32277423","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1007/s40620-020-00732-1","topics":["Prevention"],"weight":1,"_version_":1666138491634843648,"score":55.027775},{"pmid":32416947,"title":"Covid-19 pandemic and digital transformation in critical care units.","text":["Covid-19 pandemic and digital transformation in critical care units.","Med Intensiva","Murillo-Cabezas, Francisco","Vigil-Martin, Eduardo","Raimondi, Nestor","Perez-Fernandez, Javier","32416947"],"journal":"Med Intensiva","authors":["Murillo-Cabezas, Francisco","Vigil-Martin, Eduardo","Raimondi, Nestor","Perez-Fernandez, Javier"],"date":"2020-05-18T11:00:00Z","year":2020,"_id":"32416947","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.medin.2020.04.004","weight":0,"_version_":1667058206750277632,"score":54.264618}]}